AI Article Synopsis

  • A study applied deep learning algorithms, specifically a conventional CNN and a recurrent CNN (CLSTM), to classify three breast cancer molecular subtypes using MRI data from 244 patients.
  • The training data showed higher accuracy with CLSTM (0.91) compared to CNN (0.79), but independent testing revealed lower accuracy (0.4-0.5). Transfer learning improved CNN accuracy to 0.91 and CLSTM to 0.83 during further testing.
  • Overall, CLSTM demonstrated better performance in tracking changes in MRI signal intensity and transfer learning was effective in enhancing classification accuracy across different datasets.

Article Abstract

Objectives: To apply deep learning algorithms using a conventional convolutional neural network (CNN) and a recurrent CNN to differentiate three breast cancer molecular subtypes on MRI.

Methods: A total of 244 patients were analyzed, 99 in training dataset scanned at 1.5 T and 83 in testing-1 and 62 in testing-2 scanned at 3 T. Patients were classified into 3 subtypes based on hormonal receptor (HR) and HER2 receptor: (HR+/HER2-), HER2+, and triple negative (TN). Only images acquired in the DCE sequence were used in the analysis. The smallest bounding box covering tumor ROI was used as the input for deep learning to develop the model in the training dataset, by using a conventional CNN and the convolutional long short-term memory (CLSTM). Then, transfer learning was applied to re-tune the model using testing-1(2) and evaluated in testing-2(1).

Results: In the training dataset, the mean accuracy evaluated using tenfold cross-validation was higher by using CLSTM (0.91) than by using CNN (0.79). When the developed model was applied to the independent testing datasets, the accuracy was 0.4-0.5. With transfer learning by re-tuning parameters in testing-1, the mean accuracy reached 0.91 by CNN and 0.83 by CLSTM, and improved accuracy in testing-2 from 0.47 to 0.78 by CNN and from 0.39 to 0.74 by CLSTM. Overall, transfer learning could improve the classification accuracy by greater than 30%.

Conclusions: The recurrent network using CLSTM could track changes in signal intensity during DCE acquisition, and achieved a higher accuracy compared with conventional CNN during training. For datasets acquired using different settings, transfer learning can be applied to re-tune the model and improve accuracy.

Key Points: • Deep learning can be applied to differentiate breast cancer molecular subtypes. • The recurrent neural network using CLSTM could track the change of signal intensity in DCE images, and achieved a higher accuracy compared with conventional CNN during training. • For datasets acquired using different scanners with different imaging protocols, transfer learning provided an efficient method to re-tune the classification model and improve accuracy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547260PMC
http://dx.doi.org/10.1007/s00330-020-07274-xDOI Listing

Publication Analysis

Top Keywords

transfer learning
24
breast cancer
12
cancer molecular
12
molecular subtypes
12
neural network
12
deep learning
12
training dataset
12
conventional cnn
12
learning applied
12
learning
9

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!